Effects of Xinfeng capsule on pulmonary function and regulatory T cells in patients of elderly-onset rheumatoid arthritis

刘健,万磊,黄传兵,汪元,刘磊,程园园,冯云霞

DOI: https://doi.org/10.3969/j.issn.1008-9691.2013.01.003

2013-01-01

Abstract:Objective To study the effects of Xinfeng capsule on pulmonary function and regulatory T cells (Treg)in elderly-onset rheumatoid arthritis(EORA). Methods A prospective study method was conducted. The 70-year-old age was set to be the lowest boundary of elderly patients with EORA. Sixty patients with EORA were randomly divided into two groups:study group(Xinfeng capsule were given,3 times a day,once 1.2 g)and control group(Fengshi Gutong capsule were given,3 times a day,once 1.2 g);30 persons having undergone healthy examination were enrolled as healthy control group. The changes of pulmonary function,clinical signs and symptoms, CD4+CD25+ Treg,CD4+CD25+CD127- Treg were observed,and the clinical curative effects were estimated before and after treatment. Results Compared with healthy control group,the pulmonary function parameters were reduced,and after treatment they were elevated in EORA patients. In the study group,the degrees of improvement in the pulmonary function parameters such as maximum voluntary ventilation(MVV)and 50% of forced expiratory flow(FEF50)were greater than those in the control group〔MVV:(82.9±11.9)% vs.(78.3±14.5)%,FEF50:(86.3±9.8)% vs.(74.9±14.1)%,both P<0.05〕. Compared with those before treatment,the integral scores of symptoms and signs and the laboratory indexes of the two treatment groups were improved after treatment. Compared with the control group,in the study group,the degrees of improvement in symptoms such as,loss of appetite(2.57±1.46 vs. 2.82±1.92),asthenic breathing(2.07±1.45 vs. 2.57±1.25),abdominal distension(1.03±1.25 vs. 1.57±1.36) etc,and of the elevation of levels of haematoglobin〔Hb(g/L):124.5±14.4 vs. 109.2±19.7〕and of the expression rate of CD4+CD25+CD127- Treg〔(4.89±0.48)% vs.(3.02±0.53)%〕were better than those in the control group (P<0.05 or P<0.01). The significant effective rate of the study group was obviously higher than that of the control group(60.0%vs. 30.0%,P<0.05). Conclusions In cases with EORA,when arthralgia and arthroncus occur,the reduction of their lung function appears. Xinfeng capsule can improve the level of pulmonary function in such patients. It is the mechanism that via up-regulating CD4+CD25+Treg and CD4+CD25+CD127-Treg,the occurrence of deposition of immune complex and inflammatory response is inhibited and the local joint symptoms and pulmonary function are improved.